Cargando…
Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin
BACKGROUND: The effect of rebamipide on repairing intestinal mucosal damage induced by nonsteroidal anti-inflammatory drugs and its mechanism remain unclear. In this study, we sought to explore the mechanism whereby rebamipide could promote the regeneration of aspirin-induced intestinal mucosal dama...
Autores principales: | Lai, Yu, Zhong, Wa, Yu, Tao, Xia, Zhong-Sheng, Li, Jie-Yao, Ouyang, Hui, Shan, Ti-Dong, Yang, Hong-Sheng, Chen, Qi-Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489841/ https://www.ncbi.nlm.nih.gov/pubmed/26135128 http://dx.doi.org/10.1371/journal.pone.0132031 |
Ejemplares similares
-
Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms
por: Mizukami, Kazuhiro, et al.
Publicado: (2012) -
Gastroduodenal Mucosal Injury in Patients Taking Low-Dose Aspirin and the Role of Gastric Mucoprotective Drugs: Possible Effect of Rebamipide
por: Yamamoto, Takatsugu, et al.
Publicado: (2010) -
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury
por: Ota, Kazuhiro, et al.
Publicado: (2016) -
Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model
por: Kurata, Satoshi, et al.
Publicado: (2015) -
Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity
por: Kim, Jeong Ho, et al.
Publicado: (2014)